These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27393466)

  • 1. [Not Available].
    Goirand F; Royer B; Hulin A; Saint-Marcoux F;
    Therapie; 2011; 66(1):57-61. PubMed ID: 27393466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Level of evidence for therapeutic drug monitoring of everolimus].
    Goirand F; Royer B; Hulin A; Saint-Marcoux F;
    Therapie; 2011; 66(1):57-61. PubMed ID: 21466779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Drug Monitoring of Everolimus: A Consensus Report.
    Shipkova M; Hesselink DA; Holt DW; Billaud EM; van Gelder T; Kunicki PK; Brunet M; Budde K; Barten MJ; De Simone P; Wieland E; López OM; Masuda S; Seger C; Picard N; Oellerich M; Langman LJ; Wallemacq P; Morris RG; Thompson C; Marquet P
    Ther Drug Monit; 2016 Apr; 38(2):143-69. PubMed ID: 26982492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Barrail-Tran A; Taburet AM; Poirier JM;
    Therapie; 2011; 66(3):239-46. PubMed ID: 27393204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Charles M; Le Guellec C; Richard D; Libert F;
    Therapie; 2011; 66(2):103-8. PubMed ID: 27393644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Solas C; Muret P;
    Therapie; 2011; 66(3):213-9. PubMed ID: 27393201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Muret P; Solas C;
    Therapie; 2011; 66(3):207-12. PubMed ID: 27393200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Solas C; Paré M; Quaranta S; Stanke-Labesque F;
    Therapie; 2011; 66(3):221-30. PubMed ID: 27393202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Bouchet S; Royer B; Le Guellec C; Titier K;
    Therapie; 2010; 65(3):213-8. PubMed ID: 27392989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Barrail-Tran A; Taburet AM; Poirier JM;
    Therapie; 2011; 66(3):231-8. PubMed ID: 27393203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship.
    Deppenweiler M; Falkowski S; Saint-Marcoux F; Monchaud C; Picard N; Laroche ML; Tubiana-Mathieu N; Venat-Bouvet L; Marquet P; Woillard JB
    Pharmacol Res; 2017 Jul; 121():138-144. PubMed ID: 28473246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Muret P; Piedoux S; Solas C; Quaranta S;
    Therapie; 2011; 66(3):187-95. PubMed ID: 27393198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
    Shihab F; Christians U; Smith L; Wellen JR; Kaplan B
    Transpl Immunol; 2014 Jun; 31(1):22-32. PubMed ID: 24861504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study.
    Rostaing L; Christiaans MH; Kovarik JM; Pascual J
    Ann Transplant; 2014 Jul; 19():337-45. PubMed ID: 25017487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
    Kovarik JM; Snell GI; Valentine V; Aris R; Chan CK; Schmidli H; Pirron U
    J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Solas C; Gagnieu MC;
    Therapie; 2011; 66(3):197-205. PubMed ID: 27393199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure-efficacy relationships of a fingolimod-everolimus regimen in kidney transplant patients at risk for delayed graft function.
    Kovarik JM; Tedesco-Silva H; Lorber MI; Foster C
    Transplant Proc; 2006 Dec; 38(10):3479-82. PubMed ID: 17175310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 27393462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic drug monitoring of clozapine].
    Djerada Z; Daviet F; Llorca PM; Eschalier A; Saint-Marcoux F; Bentué-Ferrer D; Libert F;
    Therapie; 2023; 78(5S):S67-S74. PubMed ID: 27771104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.